AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Galacto-Oligosaccharide Market 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. & Clasado BioSciences | Technavio

November 11, 2019 GMT
Global Galacto-Oligosaccharide Market 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. & Clasado BioSciences | Technavio
Global Galacto-Oligosaccharide Market 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. & Clasado BioSciences | Technavio

LONDON--(BUSINESS WIRE)--Nov 11, 2019--

The global galacto-oligosaccharide market size is poised to grow by USD 498.15 million during 2020-2024, according to a new report by Technavio, progressing at a CAGR of close to 10% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191111005385/en/

Technavio has announced its latest market research report titled global galacto-oligosaccharide market 2020-2024. (Graphic: Business Wire)

Read the 139-page research report with TOC on “Galacto-Oligosaccharide Market Analysis Report by Product (Syrup and Powder) and Geography (North America, Europe, Asia, and ROW) 2020-2024”.

The market is driven by the health benefits of galacto-oligosaccharide. Also, the use of nutraceuticals and prebiotics in treating chronic diseases is anticipated to further boost the growth of the galacto-oligosaccharide market.

The health benefits of galacto-oligosaccharide will drive the growth of the market during the forecast period. Galacto-oligosaccharide are prebiotics and non-digestible food ingredients that benefit the host by stimulating the growth and activity of good bacteria in the gut. This results in a number of effects which include stimulation of immune functions, the absorption of essential nutrients, the production of powerful anti-oxidant H2 gas, and the synthesis of certain vitamins and minerals. As a result, galacto-oligosaccharides are increasingly being used in applications such as prebiotics and nutritional supplements in the healthcare industry.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Galacto-Oligosaccharide Companies:

Baolingbao Biology Co. Ltd.

Baolingbao Biology Co. Ltd. has business operations under various segments, which include oligosaccharides series, fructose series, dietary fiber, starch sugar, feed series, and others. The company provides galacto-oligosaccharides in the powder and syrup form for the food and beverage, animal feed, pharmaceutical, and personal care sectors.

Clasado BioSciences

Clasado BioSciences develops and manufactures advanced galacto-oligosaccharide products for the food, healthcare, and pharmaceutical companies in the global wellness market. The company’s offerings include Bimuno, a daily fiber supplement containing galacto-oligosaccharides, which feeds and stimulates the growth of good bacteria in the gut.

Fonterra Co-operative Group Ltd.

Fonterra Co-operative Group Ltd. operates under three segments, namely ingredients, consumer and foodservice, and china farms. The company’s key offerings include NZMP SureStart GOS. It is a prebiotic supplement added to infant formula products to make them closer to the composition of breast milk. This product is developed for mothers who cannot or choose not to breastfeed. The SureStart galacto-oligosaccharide is available as GOS 57 Syrup, GOS 70 Syrup, and powder.

Ingredion Inc.

Ingredion Inc. has business operations in various geographic segments, including North America, South America, APAC, and EMEA. The company’s key offerings include BIOLIGO GL 5700 IMF, which is a soluble dietary fiber made from lactose in the form of a syrup that contains 57% galacto-oligosaccharide (dry basis).

Lactose (India) Ltd.

Lactose (India) Ltd. is engaged in the business of manufacturing and trading of pharmaceutical products. The company offers Prebiotic-galacto-oligosaccharide, which is produced through the enzymatic conversion of lactose and is available in the powder form.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Galacto-Oligosaccharide Product Outlook (Revenue, USD Million, 2020-2024)

  • Syrup
  • Powder

Galacto-Oligosaccharide Regional Outlook (Revenue, USD Million, 2020-2024)

  • North America
  • Europe
  • Asia
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

Related Reports on Health Care are:

Antifreeze Proteins Market – Antifreeze Proteins Market by Application (Healthcare, Cosmetics, F&B, and Others) and Geography (North America, Europe, Asia, and ROW).

Proteinuria Therapeutics Market – Proteinuria Therapeutics Market by Product (ACE inhibitors, ARBs, and Other therapeutics) and Geography (North America, Europe, Asia, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191111005385/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com.

Website:https://www.technavio.com/

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 11/11/2019 12:00 PM/DISC: 11/11/2019 12:01 PM

http://www.businesswire.com/news/home/20191111005385/en